Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2000
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
10/19/2000WO2000061565A1 Propynyl uracils
10/19/2000WO2000061564A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061563A1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
10/19/2000WO2000061561A1 Cyanoguanidine compounds
10/19/2000WO2000061558A1 Remedies for neuropathic pain
10/19/2000WO2000061557A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000WO2000061556A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061537A2 Pharmaceutical compounds
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
10/19/2000DE19908767A1 New stable, modified epothilone derivatives, are cell division regulators useful for treating malignant tumors, angiogenesis or chronic inflammatory disease
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2369695A1 Agent for treating neuropathic pain
10/19/2000CA2369691A1 4-hydroxypiperidine derivatives having antiarrhythmic effect
10/19/2000CA2369103A1 Nitrogen-containing heterocyclic compounds and benamide compounds and drugs containing the same
10/19/2000CA2368458A1 Propynyl uracils
10/19/2000CA2368049A1 Integrin receptor ligands
10/18/2000EP1044974A1 N-hydroxyurea derivative and medicine containing the same
10/18/2000EP1044972A1 5,6,7-TRINOR-4,8-INTER-m-PHENYLENE PGI2 DERIVATIVE AND DRUGS CONTAINING THE SAME
10/18/2000EP1044971A1 Taxane derivatives
10/18/2000EP1044970A1 Aminotriazole compounds, process for their preparation and pharmaceutical compositions containing them
10/18/2000EP1044969A2 Processes and intermediates for preparing anti-cancer compounds
10/18/2000EP1044967A2 2-Pyridinylguanidine urokinase inhibitors
10/18/2000EP1044200A1 Preparation of terazosin hydrochloride dihydrate
10/18/2000EP1044197A2 New piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/18/2000EP1044191A2 Benzylidene pyrazolones, production and use thereof
10/18/2000EP1044066A1 Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
10/18/2000EP1043995A1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/18/2000EP0773965B1 Gas phase production of polydienes
10/18/2000CN1270587A New taxane derivatives
10/18/2000CN1270581A 2,6-dichloro-4-pyridinemethanol derivatives and agricultural chemicals
10/18/2000CN1270580A Inhibition of pulp and paper yellowing using nitroxides and other coadditives
10/18/2000CN1270172A Preparation of d4T from 5-methyl uridine
10/18/2000CN1270169A Benzopyrane derivatives and preparation thereof
10/18/2000CN1057443C Method for preparing antiviral medicinal compositions
10/17/2000US6133459 Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
10/17/2000US6133456 Dimers of the macrocyclic natural product, fk506, covalently attached to each other via a synthetic linker moiety
10/17/2000US6133446 Heterocyclic compounds for the treatment of CNS and cardiovascular disorders
10/17/2000US6133442 For the treatment of disorders which are associated with endothelin activities, especially circulatory disorders such as hypertension, ischaemia, vasospasms and angina pectoris
10/17/2000US6133307 2-benzofuran-4-yl-n-(2-(3-hydroxy-pyrrolidin-1-yl)-1-phenyl-ethyl) -n-methyl-acetamide, for example; treatment of arthritis, hypertension, pain, inflammation, migraine, inflammatory gastrointestinal disorders and psoriasis
10/17/2000US6133303 Various indene derivatives, with the exception of 5-(2-imidazole-1-yl-ethoxy)indan-1-one; treating cancer and treating or preventing restenosis or atherosclerosis
10/17/2000US6133296 Substituted pyridyl keto enols
10/17/2000US6133289 Paroxetine hydrochloride form A or C
10/17/2000US6133283 Mono- or polyenic carboxylic acid derivatives
10/17/2000US6133277 Little or no vasoconstrictor activity; gastrointestinal disorders, e.g. dyspepsia, early satiety, bloating and anorexia; 1-(3-((3,4-dihydro-2h-1-benzopyran-2-yl)methyl)-amino)-propyl)-tetrahydro -2(1h)-primidinone
10/17/2000US6133276 A ligand inhibitor of a crf/crf-binding protein complex to effect increased levels of crf; 2,4-dioxo- or 2-thiocarbonyl-4-oxo-5-(hydrocarbyl(thio)carbonylaminomethyl)-6-hydroxy-hexa-hexahydropyrimidines; alzheimer's, obesity; low side effects
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133269 Polymorphic form of doxazosin mesylate (form II)
10/17/2000US6133268 1,4-disubstituted piperazines
10/17/2000US6133264 Carbostyril derivatives for inhibiting skin erythema and/or skin pigmentation
10/17/2000US6133257 Fused polycyclic 2-aminopyrimidine derivatives
10/17/2000US6131226 1,4-dihydropyridine compounds as bradykinin antagonists
10/17/2000CA2001205C Antimicrobial quinolonyl lactams
10/15/2000CA2305940A1 Aminotriazol compounds, the process for preparing them and the pharmaceutical compositions containing them
10/13/2000CA2305047A1 2-pyridinylguanidine urokinase inhibitors
10/12/2000WO2000059905A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS
10/12/2000WO2000059868A1 Substituted aniline compounds
10/12/2000WO2000059510A1 Aminopyrimidines as sorbitol dehydrogenase inhibitors
10/12/2000WO2000059506A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD
10/12/2000WO2000059503A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059497A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000WO2000059304A1 Compositions and methods for preventing and treating sexual dysfunctions
10/12/2000WO1993012754A3 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
10/12/2000CA2369557A1 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of gabaa receptors
10/12/2000CA2369238A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2000CA2368703A1 Substituted aniline compounds
10/12/2000CA2366944A1 Pyrrolidine modulators of chemokine receptor activity
10/12/2000CA2366858A1 Sorbitol dehydrogenase inhibitors
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043322A1 Vitamin e derivatives
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043314A1 Novel dihydropyridine derivative
10/11/2000EP1042319A1 Dihydrobenzofurans
10/11/2000EP1042318A1 Process for the preparation of paroxetine hydrochloride
10/11/2000EP1042313A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity
10/11/2000EP1042300A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
10/11/2000EP1042296A1 Substituted isoquinoline derivatives and their use as anticonvulsants
10/11/2000EP1042295A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
10/11/2000EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
10/11/2000EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042280A2 Prodrugs of aspartyl protease inhibitors
10/11/2000EP1042272A1 Derivatives of 2,2-dimethyl 3-(2-fluoro vinyl) cyclopropane carboxylic acid, their preparation process and their use as pesticides
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/11/2000EP0650485B1 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
10/11/2000CN1269794A 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof and process for preparation of both
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/10/2000US6130335 N-([1,2,4]triazoloazinyl) benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides
10/10/2000US6130333 Bicyclic imidazolyl derivatives as phosphodiesterase inhibitors, pharmaceutical compositions and method of use
10/10/2000US6130326 L-ribavirin. oh; anticarcinogenic/antitumor agents; viricides; fungicides; treatment of autoimmune diseases
10/10/2000US6130243 1,4-benzodioxin derivatives
10/10/2000US6130239 Inhibit cyclin-dependent kinases
10/10/2000US6130238 3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors
10/10/2000US6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
10/10/2000US6130232 Substituted piperidine derivatives as muscarinic M3 receptor antagonists
10/10/2000US6130222 Analgesics
1 ... 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 ... 694